Visikol
Edit info- Founded: 2016
- Location: Hampton, NJ
- Employee range: 11 - 50
- Funding: <10M
visikol.com linkedin.com job board
Business:
Contract Research, High Content Screening, 3D cell models, ADMET/PKDM
About:
imaging technologies for biomedical research. They create custom 3D cell culture models that can be used alongside cell viability assays for in vitro screening of newly developed drugs, providing reliable data on drug efficacy and safety. Visikol aims to lessen the cap between in vitro testing and in vivo results by enhancing researchers' ability to study diseases, drug efficacy, and tissue morphology. In addition, they sell tissue clearing reagents and kits that assist in the cell imaging process to better visualize cellular changes. These customizable services and products from Visikol provide sensitive and effective alternatives to extensive animal research.
Jobs:
News:
3D Cell Culture Technologies Global Market Report 2024-2033: Size, Share & Trends Analysis By Top Research ... - WhaTech
googlenews
Nov 26, 2024
Science/business updates
external-link
New to Visikol's offerings and services? View our convenient overview here-->
https://hubs.ly/Q02YXZMD0
linkedin
Dec 13, 2024
Science/business updates
external-link
Getting to know you: New leader of NJII, Johnson, wants people to know more about how it’s accelerating innovation - ROI-NJ.com
googlenews
Dec 1, 2023
New hires
external-link
2024 projects are coming to an end, but planning for 2025 is just beginning. View our catalog with our offerings here --> https://hubs.ly/Q02YXpJf0
linkedin
Dec 6, 2024
Science/business updates
external-link
Read an article about quantification of blood vessels in placenta tissue, contributed to by our scientists
web
Dec 27, 2024
Science/business updates
external-link
How Our In Vitro Immuno-Oncology Immune Cell Infiltration Assay Can Accelerate Drug Discovery
linkedin
Nov 27, 2024
Science/business updates
external-link
Visikol acquired by Sweden-based CELLINK for up to $19.5M - ROI-NJ.com
googlenews
May 21, 2021
Funding-related
external-link
New Tissue Clearing Kits and Reagents for Faster, Accurate 3D Imaging - Labmate Online
googlenews
May 23, 2019
Science/business updates
external-link
recently published in PLOS Neglected Tropical Diseases
web
Dec 27, 2024
Science/business updates
external-link
Accelerating Drug Discovery with Advanced In Vitro Models
web
Dec 27, 2024
Science/business updates
external-link
NJ’s research organizations boost pharmaceutical discoveries (updated) - NJBIZ
googlenews
May 8, 2023
Science/business updates
external-link
Accelerating Drug Discovery with In Vitro Antibody Pharmacokinetics Assay
web
Dec 27, 2024
Science/business updates
external-link
A 27-year-old CEO named to the Forbes '30 Under 30' list gives his 2 best pieces of entrepreneurship advice - Business Insider
googlenews
Jan 10, 2017
New hires
external-link
“Ki-67 acts as a biological surfactant to disperse mitotic chromosomes”
web
Dec 27, 2024
Science/business updates
external-link
Maximizing Drug Efficacy with In Vitro Blood Brain Barrier Permeability Assessment
web
Dec 27, 2024
Science/business updates
external-link
In Vitro Models: An Alternative to In Vivo Studies
linkedin
Dec 6, 2024
Science/business updates
external-link
In this video, a breast cancer tissue micro array is labeled using CD68, PanCK, CD8, Granzyme B, CD3, Ki67, PDL1, CD45ro, PD-1, MHC-II, CD11b, and CD20. The tissue was labeled and imaged using Visikol
linkedin
Nov 27, 2024
Science/business updates
external-link
Transferrin Receptor-Mediated Uptake at the Blood–Brain Barrier Is Not Impaired by Alzheimer’s Disease Neuropathology.
web
Dec 27, 2024
Science/business updates
external-link
Newly Acquired Visikol Credits Robust NJ Innovation Ecosystem with Fueling its Success - NJEDA (.gov)
googlenews
Jun 10, 2021
Science/business updates
external-link
Accelerating Drug Discovery with High-Content Screening using HUREL® Micro Livers
web
Dec 27, 2024
Science/business updates
external-link
How Visikol is Using AI and Machine Learning to Improve High-Throughput Imaging
linkedin
Dec 20, 2024
Science/business updates
external-link
NJII President Eyes Sustainable Growth - njbmagazine.com
googlenews
Oct 20, 2023
Science/business updates
external-link
The Impact of pH on Antigen Retrieval in Immunohistochemistry
linkedin
Nov 27, 2024
Science/business updates
external-link
How Our In Vitro Immuno-Oncology Immune Cell Infiltration Assay Can Accelerate Drug Discovery
web
Dec 27, 2024
Science/business updates
external-link
New Jersey Innovation Institute Names Michael Johnson as Next President - NJIT News |
googlenews
Aug 30, 2023
New hires
external-link
“Initiation and termination of DNA replication during S phase in relation to cyclins D1, E and A, p21WAF1, Cdt1 and the p12 subunit of DNA polymerase δ revealed in individual cells by cytometry”
web
Dec 27, 2024
Science/business updates
external-link
Maximizing the Potential of Liver Fibrosis Assay
web
Dec 27, 2024
Science/business updates
external-link
© 2024 Work In Biotech LLC
Personal dataTerms of ServicePrivacy PolicyContact: recruit@workinbiotech.com
Personal dataTerms of ServicePrivacy PolicyContact: recruit@workinbiotech.com